Wealthcare Advisory Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Wealthcare Advisory Partners's FBT Position: Q2 2026 in Review
Wealthcare Advisory Partners opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 891 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #1009 among its holdings. This is a return to the name: Wealthcare Advisory Partners previously reported a position in FBT as recently as Q1 2021.
Wealthcare Advisory Partners first reported a position in FBT in Q3 2017 and has held it in 13 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Wealthcare Advisory Partners held 891 shares of First Trust NYSE Arca Biotechnology Index Fund worth $221K as of Q2 2026.
- First Trust NYSE Arca Biotechnology Index Fund was a new Wealthcare Advisory Partners position in Q2 2026.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #1009 holding.
- Wealthcare Advisory Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2017 and has held it in 13 quarters since.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.